Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

NCT: NCT07135596 · RECRUITING

NCT IDNCT07135596
StatusRECRUITING
Start Date2026-04-10
SponsorTela Bio Inc (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑